mindBEAGLE: The first EEG-based BCI System Ever for Communication with Complete Locked-in Patients

Graz,  Frontiers in Neuroscience recently published an article presenting mindBEAGLE as the very first and only EEG-based Brain-Computer Interface (BCI) that enables communication with patients who suffer from locked-in syndrome (LIS), complete locked-in syndrome (CLIS) or disorders of consciousness (DOC). It is widely known that these patients need BCIs that do not rely on visual … Skaityti toliau

ESMO welcomes the adoption of the 2017 WHO Cancer Resolution

 Lugano, 30 May 2017– ESMO, the leading European professional organisation for medical oncology, welcomes the adoption of the Resolution on Cancer prevention and control in the context of an integrated approach [http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_ACONF9-en.pdf] during the 70th World Health Assembly (WHA), 22-31 May,iGeneva, Switzerland. ESMO President Fortunato Ciardiello said “ESMO welcomes the WHO resolution that aims to … Skaityti toliau

TESARO Announces Approval of VARUBY® (Oral Rolapitant Tablets) by European Commission

  Company: TESARO, Inc.     — VARUBY provides protection for delayed chemotherapy-induced nausea and   vomiting (CINV) with a single dose as part of an antiemetic regimen   — Up to 50% of patients undergoing highly or moderately emetogenic   chemotherapy experience delayed CINV even when prescribed a 5-HT 3   receptor antagonist and … Skaityti toliau

Aegerion Pharmaceuticals Observes World Lipodystrophy Day

CAMBRIDGE, Mass., 2016-03-31 09:00 CEST (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating rare diseases, announced today its observance of World Lipodystrophy Day. Chief Executive Officer Mary Szela said, „We support the Association of Families Affected by Lipodystrophies in Spain, Europe … Skaityti toliau